Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gall stone dissolving agents.

I A Bouchier

    British Medical Journal (Clinical Research Ed.)
    |March 5, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Chenodeoxycholic acid and ursodeoxycholic acid are effective for medical dissolution of cholesterol gallstones. This review details their use, comparison, and role in gallstone management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cortical Atrophy of the Brain in Infants associated with Failure to Thrive.

    Archives of disease in childhood·2010
    Same author

    Second time round.

    British medical journal·2010
    Same author

    Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis.

    The American journal of gastroenterology·1998
    Same author

    Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites.

    Gastroenterology·1998
    Same author

    Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt.

    European journal of gastroenterology & hepatology·1998
    Same author

    Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.

    Gut·1998
    Same journal

    Early retirement for consultants.

    British medical journal (Clinical research ed.)·2010
    Same journal

    From COMAR: Essential troika of teaching, research, and clinical care.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Parliament's two way pull on the NHS.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Conference Report: After the summit.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Council election: South Western regional vacancy 1988-90.

    British medical journal (Clinical research ed.)·2010
    Same journal

    Health managers support taxation based service.

    British medical journal (Clinical research ed.)·2010
    See all related articles

    Area of Science:

    • Gastroenterology and Hepatology
    • Pharmacology

    Background:

    • Medical dissolution of gallstones has advanced significantly over the past decade.
    • While several drugs exist, chenodeoxycholic acid and ursodeoxycholic acid are the most evaluated and effective options.
    • Previous reviews, such as in 1976, had limited data on chenodeoxycholic acid's efficacy.

    Purpose of the Study:

    • To review the efficacy and applications of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution.
    • To compare the effectiveness of these two bile acids in treating gallstones.
    • To assess the current role of medical dissolution in overall gallstone management.

    Main Methods:

    • Review of existing clinical data and literature on chenodeoxycholic acid and ursodeoxycholic acid.
    • Evaluation of drug effectiveness based on British National Formulary listings and intensive studies.

    Related Experiment Videos

  • Analysis of treatment outcomes for cholesterol gallstones amenable to oral dissolution.

    • Main Results:

    • Chenodeoxycholic acid and ursodeoxycholic acid are effective for dissolving cholesterol gallstones.
    • Experience and understanding of chenodeoxycholic acid's indications have grown since 1976.
    • Data for ursodeoxycholic acid is currently being evaluated, showing promise.

    Conclusions:

    • Oral dissolution is a viable treatment option for cholesterol gallstones.
    • Chenodeoxycholic acid and ursodeoxycholic acid represent key pharmacological agents in this therapeutic area.
    • Further evaluation is needed to fully establish the place of these drugs in gallstone management, including common bile duct stones.